Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Abreha T, Adam I, Anstey NM, Assefa A, Awab GR, Baird JK, Barber BE, Chu CS, Dahal P, Daher A, Davis TME, Dondorp AM, Grigg MJ, Humphreys GS, Hwang J, Karunajeewa H, Laman M, Lidia K, Moore BR, Mueller I, Nosten F, Pasaribu AP, Pereira DB, Phyo AP, Poespoprodjo JR, Sibley CH, Stepniewska K, Sutanto I, Thwaites G, Hien TT, White NJ, William T, Woodrow CJ, Guerin PJ, Price RN.

PLoS Med. 2019 Oct 4;16(10):e1002928. doi: 10.1371/journal.pmed.1002928. eCollection 2019 Oct.

2.

IgM in human immunity to Plasmodium falciparum malaria.

Boyle MJ, Chan JA, Handayuni I, Reiling L, Feng G, Hilton A, Kurtovic L, Oyong D, Piera KA, Barber BE, William T, Eisen DP, Minigo G, Langer C, Drew DR, de Labastida Rivera F, Amante FH, Williams TN, Kinyanjui S, Marsh K, Doolan DL, Engwerda C, Fowkes FJI, Grigg MJ, Mueller I, McCarthy JS, Anstey NM, Beeson JG.

Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.

3.

Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection.

Oyong DA, Loughland JR, SheelaNair A, Andrew D, Rivera FDL, Piera KA, William T, Grigg MJ, Barber BE, Haque A, Engwerda CR, McCarthy JS, Anstey NM, Boyle MJ.

Malar J. 2019 Sep 18;18(1):312. doi: 10.1186/s12936-019-2962-0.

4.

Induction and kinetics of complement-fixing antibodies against Plasmodium vivax MSP3α and relationship with IgG subclasses and IgM.

Oyong DA, Wilson DW, Barber BE, William T, Jiang J, Galinski MR, Fowkes FJI, Grigg MJ, Beeson JG, Anstey NM, Boyle MJ.

J Infect Dis. 2019 Aug 17. pii: jiz407. doi: 10.1093/infdis/jiz407. [Epub ahead of print]

PMID:
31419296
5.

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T, Alemu SG, Añez A, Anstey NM, Aseffa A, Assefa A, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Grigg MJ, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Taylor WRJ, Thwaites G, Tran BQ, Hien TT, Vieira JLF, Wangchuk S, Watson J, William T, Woodrow CJ, Nosten F, Guerin PJ, White NJ, Price RN.

BMC Med. 2019 Aug 1;17(1):151. doi: 10.1186/s12916-019-1386-6.

6.

Whole genome sequencing of amplified Plasmodium knowlesi DNA from unprocessed blood reveals genetic exchange events between Malaysian Peninsular and Borneo subpopulations.

Benavente ED, Gomes AR, De Silva JR, Grigg M, Walker H, Barber BE, William T, Yeo TW, de Sessions PF, Ramaprasad A, Ibrahim A, Charleston J, Hibberd ML, Pain A, Moon RW, Auburn S, Ling LY, Anstey NM, Clark TG, Campino S.

Sci Rep. 2019 Jul 8;9(1):9873. doi: 10.1038/s41598-019-46398-z.

7.

Whole-Genome Sequencing to Differentiate Relapse From Reinfection in Community-Onset Bacteremic Acinetobacter baumannii Pneumonia.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Baird R, Sarovich DS, Davis JS.

Open Forum Infect Dis. 2019 Jun 1;6(7):ofz263. doi: 10.1093/ofid/ofz263. eCollection 2019 Jul.

8.

Antiphosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associated With Early Anemia in Both Species.

Barber BE, Grigg MJ, Piera K, Amante FH, William T, Boyle MJ, Minigo G, Dondorp AM, McCarthy JS, Anstey NM.

J Infect Dis. 2019 Sep 26;220(9):1435-1443. doi: 10.1093/infdis/jiz334.

PMID:
31250022
9.

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.

Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, Prayoga, Thio F, Devine A, Marfurt J, Waramori G, Yeung S, Noviyanti R, Penttinen P, Bangs MJ, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN.

PLoS Med. 2019 May 29;16(5):e1002815. doi: 10.1371/journal.pmed.1002815. eCollection 2019 May.

10.

Environmental risk factors and exposure to the zoonotic malaria parasite Plasmodium knowlesi across northern Sabah, Malaysia: a population-based cross-sectional survey.

Fornace KM, Brock PM, Abidin TR, Grignard L, Herman LS, Chua TH, Daim S, William T, Patterson CLEB, Hall T, Grigg MJ, Anstey NM, Tetteh KKA, Cox J, Drakeley CJ.

Lancet Planet Health. 2019 Apr;3(4):e179-e186. doi: 10.1016/S2542-5196(19)30045-2.

11.

Predictive analysis across spatial scales links zoonotic malaria to deforestation.

Brock PM, Fornace KM, Grigg MJ, Anstey NM, William T, Cox J, Drakeley CJ, Ferguson HM, Kao RR.

Proc Biol Sci. 2019 Jan 16;286(1894):20182351. doi: 10.1098/rspb.2018.2351.

12.

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.

Setyadi A, Arguni E, Kenangalem E, Hasanuddin A, Lampah DA, Thriemer K, Anstey NM, Sugiarto P, Simpson JA, Price RN, Douglas NM, Poespoprodjo JR.

Malar J. 2019 Apr 2;18(1):111. doi: 10.1186/s12936-019-2745-7.

13.

Does reduced oxygen delivery cause lactic acidosis in falciparum malaria? An observational study.

Kingston HW, Ghose A, Rungpradubvong V, Herdman MT, Plewes K, Ishioka H, Leopold SJ, Maude RJ, Intharabut B, Mohanty S, Day NPJ, White NJ, Hossain MA, Anstey NM, Dondorp AM.

Malar J. 2019 Mar 25;18(1):97. doi: 10.1186/s12936-019-2733-y.

14.

Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study.

Lestari T, Graham S, van den Boogard C, Triasih R, Poespoprodjo JR, Ubra RR, Kenangalem E, Mahendradhata Y, Anstey NM, Bailie RS, Ralph AP.

Implement Sci. 2019 Mar 19;14(1):31. doi: 10.1186/s13012-019-0870-x.

15.

Plasmodium knowlesi malaria in Sabah, Malaysia, 2015-2017: ongoing increase in incidence despite near-elimination of the human-only Plasmodium species.

Cooper DJ, Rajahram GS, William T, Jelip J, Mohammad R, Benedict J, Alaza DA, Malacova E, Yeo TW, Grigg MJ, Anstey NM, Barber BE.

Clin Infect Dis. 2019 Mar 19. pii: ciz237. doi: 10.1093/cid/ciz237. [Epub ahead of print]

PMID:
30889244
16.

Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Kenyon JJ, Hall RM, Davis JS, Sarovich DS.

Microb Genom. 2019 Mar;5(3). doi: 10.1099/mgen.0.000258. Epub 2019 Feb 26.

17.

Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.

Yeo TW, Weinberg JB, Lampah DA, Kenangalem E, Bush P, Chen Y, Price RN, Young S, Zhang HY, Millington D, Granger DL, Anstey NM.

Clin Infect Dis. 2019 Feb 12. doi: 10.1093/cid/ciz038. [Epub ahead of print]

PMID:
30753363
18.

Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria.

Rubach MP, Zhang H, Florence SM, Mukemba JP, Kalingonji AR, Anstey NM, Yeo TW, Lopansri BK, Thompson JW, Mwaikambo ED, Young S, Millington DS, Weinberg JB, Granger DL.

Infect Immun. 2019 Mar 25;87(4). pii: e00655-18. doi: 10.1128/IAI.00655-18. Print 2019 Apr.

19.

Genomic analysis of Plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms.

Auburn S, Getachew S, Pearson RD, Amato R, Miotto O, Trimarsanto H, Zhu SJ, Rumaseb A, Marfurt J, Noviyanti R, Grigg MJ, Barber B, William T, Goncalves SM, Drury E, Sriprawat K, Anstey NM, Nosten F, Petros B, Aseffa A, McVean G, Kwiatkowski DP, Price RN.

J Infect Dis. 2019 Jan 21. doi: 10.1093/infdis/jiz016. [Epub ahead of print]

PMID:
30668735
20.

Deaths from Plasmodium knowlesi malaria: case series and systematic review.

Rajahram GS, Cooper DJ, William T, Grigg MJ, Anstey NM, Barber BE.

Clin Infect Dis. 2019 Jan 8. doi: 10.1093/cid/ciz011. [Epub ahead of print]

PMID:
30624597
21.

Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance.

Grigg MJ, William T, Piera KA, Rajahram GS, Jelip J, Aziz A, Menon J, Marfurt J, Price RN, Auburn S, Barber BE, Yeo TW, Anstey NM.

Malar J. 2018 Dec 10;17(1):463. doi: 10.1186/s12936-018-2593-x.

22.

Laboratory challenges of Plasmodium species identification in Aceh Province, Indonesia, a malaria elimination setting with newly discovered P. knowlesi.

Coutrier FN, Tirta YK, Cotter C, Zarlinda I, González IJ, Schwartz A, Maneh C, Marfurt J, Murphy M, Herdiana H, Anstey NM, Greenhouse B, Hsiang MS, Noviyanti R.

PLoS Negl Trop Dis. 2018 Nov 30;12(11):e0006924. doi: 10.1371/journal.pntd.0006924. eCollection 2018 Nov.

23.

Case Report: Severe Disseminated Gonococcal Infection with Polyarticular Gout: Two Cases in Older Travelers.

Smith EL, Hodgetts KE, Ralph AP, Anstey NM.

Am J Trop Med Hyg. 2019 Jan;100(1):209-212. doi: 10.4269/ajtmh.18-0589.

PMID:
30457099
24.

Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria.

Kho S, Minigo G, Andries B, Leonardo L, Prayoga P, Poespoprodjo JR, Kenangalem E, Price RN, Woodberry T, Anstey NM, Yeo TW.

J Infect Dis. 2019 May 24;219(12):1994-2004. doi: 10.1093/infdis/jiy661.

25.

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia.

Oyong DA, Kenangalem E, Poespoprodjo JR, Beeson JG, Anstey NM, Price RN, Boyle MJ.

JCI Insight. 2018 Nov 15;3(22). pii: 124854. doi: 10.1172/jci.insight.124854.

26.

Zoonotic Malaria: The Better You Look, the More You Find.

Anstey NM, Grigg MJ.

J Infect Dis. 2019 Feb 15;219(5):679-681. doi: 10.1093/infdis/jiy520. No abstract available.

PMID:
30295775
27.

Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.

Loughland JR, Woodberry T, Boyle MJ, Tipping PE, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, Minigo G.

J Infect Dis. 2019 Jan 29;219(4):660-671. doi: 10.1093/infdis/jiy555.

28.

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, Chu CS, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Gonzalez-Ceron L, Grigg MJ, Heidari A, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Nosten F, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Sutanto I, Taylor WRJ, Thwaites G, Tran BQ, Tran HT, Valecha N, Vieira JLF, Wangchuk S, William T, Woodrow CJ, Zuluaga-Idarraga L, Guerin PJ, White NJ, Price RN.

Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.

29.

Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Kho S, Barber BE, Johar E, Andries B, Poespoprodjo JR, Kenangalem E, Piera KA, Ehmann A, Price RN, William T, Woodberry T, Foote S, Minigo G, Yeo TW, Grigg MJ, Anstey NM, McMorran BJ.

Blood. 2018 Sep 20;132(12):1332-1344. doi: 10.1182/blood-2018-05-849307. Epub 2018 Jul 19.

30.

Antibiotic Therapy in Adults with Malaria (ANTHEM): High Rate of Clinically Significant Bacteremia in Hospitalized Adults Diagnosed with Falciparum Malaria.

Aung NM, Nyein PP, Htut TY, Htet ZW, Kyi TT, Anstey NM, Kyi MM, Hanson J.

Am J Trop Med Hyg. 2018 Sep;99(3):688-696. doi: 10.4269/ajtmh.18-0378. Epub 2018 Jul 12.

31.

Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics.

Auburn S, Benavente ED, Miotto O, Pearson RD, Amato R, Grigg MJ, Barber BE, William T, Handayuni I, Marfurt J, Trimarsanto H, Noviyanti R, Sriprawat K, Nosten F, Campino S, Clark TG, Anstey NM, Kwiatkowski DP, Price RN.

Nat Commun. 2018 Jul 3;9(1):2585. doi: 10.1038/s41467-018-04965-4.

32.

Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Bobogare A, Ley B, Gudo CS, Alam MS, Anstey NM, Ashley E, Baird JK, Gryseels C, Jambert E, Lacerda M, Laihad F, Marfurt J, Pasaribu AP, Poespoprodjo JR, Sutanto I, Taylor WR, van den Boogaard C, Battle KE, Dysoley L, Ghimire P, Hawley B, Hwang J, Khan WA, Mudin RNB, Sumiwi ME, Ahmed R, Aktaruzzaman MM, Awasthi KR, Bardaji A, Bell D, Boaz L, Burdam FH, Chandramohan D, Cheng Q, Chindawongsa K, Culpepper J, Das S, Deray R, Desai M, Domingo G, Duoquan W, Duparc S, Floranita R, Gerth-Guyette E, Howes RE, Hugo C, Jagoe G, Sariwati E, Jhora ST, Jinwei W, Karunajeewa H, Kenangalem E, Lal BK, Landuwulang C, Le Perru E, Lee SE, Makita LS, McCarthy J, Mekuria A, Mishra N, Naket E, Nambanya S, Nausien J, Duc TN, Thi TN, Noviyanti R, Pfeffer D, Qi G, Rahmalia A, Rogerson S, Samad I, Sattabongkot J, Satyagraha A, Shanks D, Sharma SN, Sibley CH, Sungkar A, Syafruddin D, Talukdar A, Tarning J, Ter Kuile F, Thapa S, Theodora M, Huy TT, Waramin E, Waramori G, Woyessa A, Wongsrichanalai C, Xa NX, Yeom JS, Hermawan L, Devine A, Nowak S, Jaya I, Supargiyono S, Grietens KP, Price RN.

Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.

33.

Identification and validation of a novel panel of Plasmodium knowlesi biomarkers of serological exposure.

Herman LS, Fornace K, Phelan J, Grigg MJ, Anstey NM, William T, Moon RW, Blackman MJ, Drakeley CJ, Tetteh KKA.

PLoS Negl Trop Dis. 2018 Jun 14;12(6):e0006457. doi: 10.1371/journal.pntd.0006457. eCollection 2018 Jun.

34.

Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.

Grigg MJ, William T, Barber BE, Rajahram GS, Menon J, Schimann E, Piera K, Wilkes CS, Patel K, Chandna A, Drakeley CJ, Yeo TW, Anstey NM.

Clin Infect Dis. 2018 Jul 18;67(3):350-359. doi: 10.1093/cid/ciy065.

35.

Intravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury.

Barber BE, Grigg MJ, Piera KA, William T, Cooper DJ, Plewes K, Dondorp AM, Yeo TW, Anstey NM.

Emerg Microbes Infect. 2018 Jun 6;7(1):106. doi: 10.1038/s41426-018-0105-2.

36.

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia.

Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, Douglas NM, Simpson JA, Sugiarto P, Anstey NM, Price RN.

Clin Infect Dis. 2019 Jan 1;68(1):51-60. doi: 10.1093/cid/ciy403.

37.

The effect of regularly dosed paracetamol versus no paracetamol on renal function in Plasmodium knowlesi malaria (PACKNOW): study protocol for a randomised controlled trial.

Cooper DJ, Plewes K, Grigg MJ, Rajahram GS, Piera KA, William T, Chatfield MD, Yeo TW, Dondorp AM, Anstey NM, Barber BE.

Trials. 2018 Apr 24;19(1):250. doi: 10.1186/s13063-018-2600-0.

38.

Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.

Plewes K, Kingston HWF, Ghose A, Wattanakul T, Hassan MMU, Haider MS, Dutta PK, Islam MA, Alam S, Jahangir SM, Zahed ASM, Sattar MA, Chowdhury MAH, Herdman MT, Leopold SJ, Ishioka H, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Lee SJ, Mukaka M, Maude RJ, Turner GDH, Faiz MA, Tarning J, Oates JA, Anstey NM, White NJ, Day NPJ, Hossain MA, Roberts Ii LJ, Dondorp AM.

Clin Infect Dis. 2018 Sep 14;67(7):991-999. doi: 10.1093/cid/ciy213.

39.

The Plasmodium falciparum transcriptome in severe malaria reveals altered expression of genes involved in important processes including surface antigen-encoding var genes.

Tonkin-Hill GQ, Trianty L, Noviyanti R, Nguyen HHT, Sebayang BF, Lampah DA, Marfurt J, Cobbold SA, Rambhatla JS, McConville MJ, Rogerson SJ, Brown GV, Day KP, Price RN, Anstey NM, Papenfuss AT, Duffy MF.

PLoS Biol. 2018 Mar 12;16(3):e2004328. doi: 10.1371/journal.pbio.2004328. eCollection 2018 Mar.

40.

Reduced red blood cell deformability in Plasmodium knowlesi malaria.

Barber BE, Russell B, Grigg MJ, Zhang R, William T, Amir A, Lau YL, Chatfield MD, Dondorp AM, Anstey NM, Yeo TW.

Blood Adv. 2018 Feb 27;2(4):433-443. doi: 10.1182/bloodadvances.2017013730.

41.

Therapeutic Response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia.

Poespoprodjo JR, Kenangalem E, Wafom J, Chandrawati F, Puspitasari AM, Ley B, Trianty L, Korten Z, Surya A, Syafruddin D, Anstey NM, Marfurt J, Noviyanti R, Price RN.

Am J Trop Med Hyg. 2018 Mar;98(3):677-682. doi: 10.4269/ajtmh.17-0662. Epub 2018 Jan 11.

42.

Disease Severity and Effective Parasite Multiplication Rate in Falciparum Malaria.

Kingston HW, Ghose A, Plewes K, Ishioka H, Leopold SJ, Maude RJ, Paul S, Intharabut B, Silamut K, Woodrow C, Day NPJ, Chotivanich K, Anstey NM, Hossain A, White NJ, Dondorp AM.

Open Forum Infect Dis. 2017 Dec 20;4(4):ofx169. doi: 10.1093/ofid/ofx169. eCollection 2017 Fall.

43.

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Devine A, Kenangalem E, Burdam FH, Anstey NM, Poespoprodjo JR, Price RN, Yeung S.

Am J Trop Med Hyg. 2018 Feb;98(2):543-550. doi: 10.4269/ajtmh.17-0680. Epub 2017 Dec 21.

44.

Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.

Grigg MJ, William T, Barber BE, Rajahram GS, Menon J, Schimann E, Wilkes CS, Patel K, Chandna A, Price RN, Yeo TW, Anstey NM.

Clin Infect Dis. 2018 Jan 6;66(2):229-236. doi: 10.1093/cid/cix779.

45.

Effects of Aging on Parasite Biomass, Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Plasmodium knowlesi and Plasmodium falciparum Malaria.

Barber BE, Grigg MJ, William T, Piera KA, Boyle MJ, Yeo TW, Anstey NM.

J Infect Dis. 2017 Jun 15;215(12):1908-1917. doi: 10.1093/infdis/jix193.

PMID:
28863470
46.

Decreased Microvascular Function in Tanzanian Children With Severe and Uncomplicated Falciparum Malaria.

Yeo TW, Florence SM, Kalingonji AR, Chen Y, Granger DL, Anstey NM, Mwaikambo ED, Weinberg JB.

Open Forum Infect Dis. 2017 Apr 22;4(2):ofx079. doi: 10.1093/ofid/ofx079. eCollection 2017 Spring.

47.

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.

Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN.

PLoS Med. 2017 Aug 29;14(8):e1002379. doi: 10.1371/journal.pmed.1002379. eCollection 2017 Aug.

48.

The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.

Thit SS, Aung NM, Htet ZW, Boyd MA, Saw HA, Anstey NM, Kyi TT, Cooper DA, Kyi MM, Hanson J.

BMC Med. 2017 Aug 4;15(1):145. doi: 10.1186/s12916-017-0888-3.

49.

Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study.

Grigg MJ, Cox J, William T, Jelip J, Fornace KM, Brock PM, von Seidlein L, Barber BE, Anstey NM, Yeo TW, Drakeley CJ.

Lancet Planet Health. 2017 Jun 9;1(3):e97-e104. doi: 10.1016/S2542-5196(17)30031-1.

50.

Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation.

Loughland JR, Minigo G, Sarovich DS, Field M, Tipping PE, Montes de Oca M, Piera KA, Amante FH, Barber BE, Grigg MJ, William T, Good MF, Doolan DL, Engwerda CR, Anstey NM, McCarthy JS, Woodberry T.

Sci Rep. 2017 Jun 1;7(1):2596. doi: 10.1038/s41598-017-02096-2.

Supplemental Content

Loading ...
Support Center